LAS INFECCIONES DE TRANSMISIÓN SEXUAL. - Euskadi.net

ción del cáncer cervical mediante modificaciones
de la conducta y estilos de
vida sexuales (Revisión Cochrane traducida).
En: La Biblioteca Cochrane Plus,
2005 Número 3. Oxford: Update Software
Ltd. Disponible en: http://www.update-software.com.
(Traducida de The
Cochrane Library, 2005 Issue 3. Chichester,
UK: John Wiley & Sons, Ltd.). Acceso
el 25/8/2005 en: http://212.49.218.203/
newgenClibPlus/pdf/CD001035-ES.pdf
227. Sherlaw-Johnson C, Philips Z. An evaluation
of liquid-based cytology and human
papillomavirus testing within the UK cervical
cancer screening programme. Br J
Cancer 2004 Jul 5; 91(1):84-91
228. Siddiqui NS, Brown LS Jr, Phillips RY, Vargas
O, Makuch RW. No seroconversions
among steady sex partners of methadone-maintained
HIV-1-seropositive injecting
drug users in New York City. AIDS
1992 Dec; 6(12):1529-33.
229. Simms I, Fenton KA, Ashton M, Turner
KM, Crawley-Boevey EE, Gorton R, Thomas
DR, Lynch A, Winter A, Fisher MJ,
Lighton L, Maguire HC, Solomou M. The
re-emergence of syphilis in the United
Kingdom: the new epidemic phases. Sex
Transm Dis 2005 Apr; 32(4):220-6.
230. Simoni JM, Pantalone DW. Secrets and
safety in the age of AIDS: does HIV disclosure
lead to safer sex Top HIV Med
2004 Oct-Nov; 12(4):109-18.
231. Slomka MJ, Emry L, Munday PE, et al. A
comparison of PCR with virus isolation
and direct antigen detection and typing
of genital herpes. J Med Virol 1998; 55:
177-183.
232. Solomon D, Schiffman M. Have we resolved
how to triage equivocal cervical cytology
J Natl Cancer Inst 2004 Feb 18;
96(4):250-1.
233. St Lawrence J, Eldridge GD, Shelby MC,
Little CE, Brasfield TL, O’Bannon RE 3rd.
HIV risk reduction for incarcerated women:
a comparison of brief interventions
based on two theoretical models. Journal
of consulting and clinical psychology
1997; 65(3):504-9.
234. Stanberry LR, Spruance SL, Cunningham
AL, Bernstein DI, Mindel A, Sacks S, Tyring
S, Aoki FY, Slaoui M, Denis M, Vandepapeliere
P, Dubin G; GlaxoSmithKline Herpes
Vaccine Efficacy Study Group. Glycoprotein-D-adjuvant
vaccine to prevent
genital herpes. N Engl J Med 2002 Nov
21; 347(21):1652-61.
235. Stanberry LR. Clinical trials of prophylactic
and therapeutic herpes simplex virus
vaccines. Herpes 2004 Aug; 11 Suppl 3:
161A-169A.
236. Steen R, Dallabetta G. Sexually transmitted
infection control with sex workers:
regular screening and presumptive treatment
augment efforts to reduce risk
and vulnerability. Reprod Health Matters
2003 Nov; 11(22):74-90.
237. Stekler J, Bachmann L, Brotman RM, Erbelding
EJ, Lloyd LV, Rietmeijer CA,
Handsfield HH, Holmes KK, Golden MR.
Concurrent sexually transmitted infections
(STIs) in sex partners of patients
with selected STIs: implications for patient-delivered
partner therapy. Clin Infect
Dis 2005 Mar 15; 40(6):787-93.
238. Stephenson JM, Imrie J, Bonell C. Effective
sexual health interventions. Issues in
experimental evaluation 2003. Oxford
University Press.
239. Sutton S, McVey D, Glanz A. A comparative
test of the theory of reasoned action
and the theory of planned behavior in
the prediction of condom use intentions
in a national sample of English young
people. Health Psychol 1999 Jan; 18(1):
72-81.
240. Sutton S. Using theories of behaviour
change to develop and evaluate sexual
health interventions. En: Stephenson JM,
Imrie J, Bonell C. Effective sexual health
172